Black queer Atlantans gathered at MODEx Studio for GLAAD Down South, an event celebrating LGBTQ+ Southerners, storytellers, ...

If we are going to defeat HIV, we cannot abandon our commitment to fully fund research, and we cannot walk away from our work ...

Gilead Sciences’ long-acting drug to block HIV has the potential to end the AIDS epidemic worldwide. But accessibility ...

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

The MoU establishes a framework for collaboration between ADPHC and Gilead Sciences across two core pillars: disease ...

No significant association was observed between viremia history during ART and CVD risk in a large international cohort of patients with HIV infection.

That shows how the company is now overvalued in our view. The largest risk to our thesis is if Gilead Sciences can achieve ...

BofA Securities Health Care Conference May 13, 2025 2:20 PM ET. Company Participants. Johanna Mercier – Chief Commercial Officer. Conference ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Gilead Sciences, Inc.

The human immunodeficiency virus (HIV) market across the seven major markets (7MM), comprising the US, France, Germany, Italy ...

Metformin use in patients with HIV and type 2 diabetes who had at least 2 years of exposure to effective ART showed no significant effect on immune reconstitution.